Insmed, Inc. (NASDAQ:INSM)

CAPS Rating: 1 out of 5

Insmed Incorporated, a biopharmaceutical company, is focused on developing and commercializing novel, targeted inhalation therapies.

INSM News and Commentary

Caps

How do you think INSM will perform against the market?

Add Stock to CAPS Watchlist

All Players

80 Outperform
13 Underperform
 

All-Star Players

17 Outperform
7 Underperform
 

Wall Street

7 Outperform
2 Underperform
 

Top INSM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

scrubs62074 (21.01)
Submitted February 12, 2013

High Volume Breakout on 02/12/13

obiwankenobe1250 (80.07)
Submitted March 03, 2007

Voraciously consuming an inordinate amount of cash relative to its revenues. Long term prospects had better pan out, because the near term looks pretty dismal. And besides, downwithpumpers provided the tip.

INSM VS S&P 500 (SPY)

Fools bullish on INSM are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about INSM.

Recs

1
Member Avatar scrubs62074 (21.01) Submitted: 2/12/2013 2:56:15 PM : Outperform Start Price: $6.07 INSM Score: +271.41

High Volume Breakout on 02/12/13

Recs

2
Member Avatar solanZRaider (< 20) Submitted: 6/26/2012 4:07:27 PM : Outperform Start Price: $3.18 INSM Score: +655.79

ZZ Top

Recs

0
Member Avatar nvcrader (52.30) Submitted: 1/21/2012 2:49:47 AM : Outperform Start Price: $5.03 INSM Score: +336.63

UPDATE 2-FDA lifts hold on Insmed's lung disease drug, shares jump

Leaderboard

Find the members with the highest scoring picks in INSM.

Score Leader

trackthinkequity

trackthinkequity (89.54) Score: +670.14

The Score Leader is the player with the highest score across all their picks in INSM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.94 8/20/2012 Outperform 5Y $3.16 +769.30% +94.15% +675.15 0 Comment
solanZRaider < 20 6/27/2012 Outperform 1Y $3.18 +763.84% +108.05% +655.79 1 Comment
popatop100 34.95 7/17/2012 Outperform 5Y $3.63 +656.75% +103.62% +553.13 0 Comment
wpson < 20 8/22/2011 Outperform 3M $3.93 +598.98% +139.21% +459.77 0 Comment
BlueInsight < 20 8/5/2011 Outperform 5Y $4.22 +550.95% +126.26% +424.68 0 Comment
craigliles < 20 9/14/2011 Outperform 5Y $4.29 +540.33% +133.71% +406.61 0 Comment
nvcrader 52.30 1/23/2012 7/27/2015 Outperform 5Y $5.03 +446.12% +109.49% +336.63 1 Comment
MFGramps 28.66 8/3/2011 Outperform 3Y $5.03 +446.12% +121.05% +325.07 0 Comment
Nappingrabbit 74.95 8/4/2011 Outperform 5Y $5.04 +445.04% +121.43% +323.61 0 Comment
somma4189 < 20 9/27/2011 Outperform 5Y $5.06 +442.89% +132.43% +310.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackWedbush 88.99 2/11/2014 Underperform NS $16.85 +63.03% +52.92% -10.11 0 Comment
TrackJMP 85.12 1/9/2014 Outperform NS $19.27 +42.55% +49.65% -7.09 0 Comment
TrackPiperJaff 87.47 11/27/2013 Outperform NS $15.86 +73.20% +52.32% +20.88 0 Comment
TrackUBS 92.13 6/18/2013 Outperform NS $13.10 +109.69% +67.45% +42.25 0 Comment
TrackLazardCapit 84.61 5/15/2013 Outperform NS $10.15 +170.64% +67.01% +103.63 0 Comment
TrackCanaccord 71.82 3/22/2013 Outperform NS $7.03 +290.75% +77.91% +212.84 0 Comment
TrackUltraLong < 20 11/26/2012 Underperform NS $7.91 +247.28% +95.88% -151.41 1 Comment
trackthinkequity 89.54 8/17/2012 Outperform NS $3.18 +763.84% +93.70% +670.14 0 Comment
TrackWedbush 88.99 9/16/2011 Outperform NS $4.83 +252.79% +49.24% +203.55 2/11/2014 @ $17.04 0 Comment
TrackRBCCapMkts 88.77 7/25/2011 Outperform NS $11.29 +143.31% +106.68% +36.64 0 Comment

Featured Broker Partners


Advertisement